⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4100563 | 0.78 | — | — | |
| SCHEMBL3763840 | 0.75 | HDAC1 (0.41) | — | |
| SCHEMBL7765796 | 0.74 | — | — | |
| SCHEMBL7467004 | 0.73 | — | — | |
| SCHEMBL10508172 | 0.73 | EGLN3 (0.45) | — | |
| SCHEMBL16402219 | 0.70 | — | — | |
| Bromide SCHEMBL6984871 | 0.70 | EGLN3 (0.62) | — | |
| SCHEMBL22234928 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL1375589 | 0.70 | EGLN3 (0.62) | — | |
| SCHEMBL1178749 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338338-B2 | Formulations comprising triazoles and alkoxylated amines | JANSSEN PHARMACEUTICA N.V. (BE) | 2012-12-25 | — | — | US | disclosed |
| US-20110196006-A1 | IMAZALIL COMPOSITIONS COMPRISING ALKOXYLATED AMINES | BYLEMANS DANY LEOPOLD JOZEFIEN | 2011-08-11 | — | — | US | disclosed |
| US-20100099724-A1 | Formulations Comprising Triazoles and Alkoxylated Amines | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-04-22 | — | — | US | disclosed |
| US-7662748-B2 | Such as azaconazole, bromuconazole, and N,N',N'-tris(2-hydroxyethyl)-N-cocoalkyl-1,3-diamino-propane; kits; for protection of crops, plants, fruits, seeds, wood products, thatch, biodegradable material and textiles | JANSSEN PHARMACEUTICA, N.V. (BE) | 2010-02-16 | — | — | US | disclosed |
| US-20090093505-A1 | Imazalil compositions comprising alkoxylated amines | JANSSEN PHARMACEUTICA N.V. (BE) | 2009-04-09 | — | — | US | disclosed |
| EP-1784076-A1 | IMAZALIL COMPOSITIONS COMPRISING ALKOXYLATED AMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-05-16 | — | — | EP | disclosed |
| EP-1473996-B1 | FORMULATIONS COMPRISING TRIAZOLES AND ALKOXYLATED AMINES | JANSSEN PHARMACEUTICA NV (BE) | 2006-04-26 | — | — | EP | disclosed |
| WO-2006021556-A1 | IMAZALIL COMPOSITIONS COMPRISING ALKOXYLATED AMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-03-02 | — | — | WO | disclosed |
| US-20050080089-A1 | Formulations comprising triazoles and alkoxylated amines | AKZO NOBEL CHEMICALS BV (NL) | 2005-04-14 | — | — | US | disclosed |
| EP-1473996-A1 | FORMULATIONS COMPRISING TRIAZOLES AND ALKOXYLATED AMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-11-10 | — | — | EP | disclosed |
| WO-2003065807-A1 | FORMULATIONS COMPRISING TRIAZOLES AND ALKOXYLATED AMINES | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-08-14 | — | — | WO | disclosed |
| EP-1273233-A1 | Preservative formulations comprising an oxathiazine and alkoxylated amines | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-01-08 | — | — | EP | disclosed |